Page 1 | Search Results | Blood | American Society of Hematology

1-17 of 17

Sort by

Sort Order Select

Journal Articles

Tumor and microenvironment response but no cytotoxic T-cell activation in classic Hodgkin lymphoma treated with anti-PD1

Blood (2020) 136 (25): 2851–2863.

https://doi.org/10.1182/blood.2020008553

Published: 2020

Includes: Supplemental data

Journal Articles

Risk of Central Nervous System (CNS) Involvement in Patients with Mantle Cell Lymphoma (MCL): Analysis of Clinico-Biological Factors in a Series of 283 Cases

Blood (2014) 124 (21): 1677.

https://doi.org/10.1182/blood.V124.21.1677.1677

Published: 2014

Journal Articles

Longitudinal Gene Expression Profiling Reveals Down-Regulation Of BCR Signaling-Related Genes In Chronic Lymphocytic Leukemia (CLL) Patients Treated With Ibrutinib Plus Rituximab

Julia Hoellenriegel, Elena Hartmann, MD, PhD, Andreas Rosenwald, MD, Susan O'Brien, MD, Michael Keating, MD, William G. Wierda, MD, PhD, Joseph J. Buggy, PhD, Jan A. Burger, MD, PhD

Blood (2013) 122 (21): 1631.

https://doi.org/10.1182/blood.V122.21.1631.1631

Published: 2013

Journal Articles

CCL3 (MIP-1α) plasma levels and the risk for disease progression in chronic lymphocytic leukemia

Mariela Sivina, Elena Hartmann, Thomas J. Kipps, Laura Rassenti, Diana Krupnik, Susan Lerner, Ruth LaPushin, Lianchun Xiao, Xuelin Huang, Lillian Werner, Donna Neuberg, Hagop Kantarjian, Susan O'Brien, William G. Wierda, Michael J. Keating, Andreas Rosenwald, Jan A. Burger

Blood (2011) 117 (5): 1662–1669.

https://doi.org/10.1182/blood-2010-09-307249

Published: 2011

Includes: Supplemental data

Journal Articles

Stroma-Induced TCL1 Expression In Chronic Lymphocytic Leukemia Cells Is Associated with Down Regulation of TCL1A-Targeting miRNAs

Mariela Sivina, Elena Hartmann, Jorge Boucas, Michael J Keating, William G. Wierda, Marco Herling, Andreas Rosenwald, Jan A. Burger

Blood (2010) 116 (21): 52.

https://doi.org/10.1182/blood.V116.21.52.52

Published: 2010

Journal Articles

Proteasome Inhibition Leads to Dephosphorylation and Downregulation of Protein Expression of Members of the Akt/mTOR Pathway In MCL

Grit Hutter, Yvonne Zimmermann, Malte Rieken, Elena Hartmann, Wolfgang Hiddemann, MD, PhD, Andreas Rosenwald, Martin H. Dreyling, MD

Blood (2010) 116 (21): 4449.

https://doi.org/10.1182/blood.V116.21.4449.4449

Published: 2010

Journal Articles

Enzastaurin Treatment Affects Multiple Regulatory Pathways at Transcriptome and Cellular Proteome Level of Mantle Cell Lymphoma

Marc Weinkauf, Grit Hutter, Yvonne Zimmermann, Malte Rieken, Alessandro Pastore, Elena Hartmann, Andreas Rosenwald, Wolfgang Hiddemann, MD, Martin H. Dreyling, MD

Blood (2010) 116 (21): 2893.

https://doi.org/10.1182/blood.V116.21.2893.2893

Published: 2010

Journal Articles

CCL3 and CCL4 Plasma Levels Correlate with Established Prognostic Markers in Chronic Lymphocytic Leukemia: Towards a Simple, ELISA-Based Assay for Risk Assessment.

Mariela Sivina, Elena Hartmann, MD, Diana Krupnik, Ruth LaPushin, Michael Keating, MD, Thomas J. Kipps, MD, PhD, Andreas Rosenwald, William G Wierda, Jan A. Burger, MD, PhD

Blood (2009) 114 (22): 358.

https://doi.org/10.1182/blood.V114.22.358.358

Published: 2009

Journal Articles

Marrow Stromal Cells Induce TCL1 Expression in Chronic Lymphocytic Leukemia B Cells.

Mariela Sivina, Elena Hartmann, MD, Michael Keating, MD, William G Wierda, Andreas Rosenwald, MD, Jan A. Burger, MD, PhD

Blood (2009) 114 (22): 2347.

https://doi.org/10.1182/blood.V114.22.2347.2347

Published: 2009

Journal Articles

Synergistic Antilymphoma Effect of Protein Kinase C Beta (PKCβ) and mTOR Inhibition in Mantle Cell Lymphoma.

Grit Hutter, Yvonne Zimmermann, Malte Rieken, Elena Hartmann, MD, Vindi Jurinovic, Andreas Rosenwald, Marc Weinkauf, Wolfgang Hiddemann, Martin H. Dreyling

Blood (2009) 114 (22): 4780.

https://doi.org/10.1182/blood.V114.22.4780.4780

Published: 2009

Journal Articles

RNA-Expression and Proteome Analysis Identify Complementary but Not Identical Molecular Targets in Enzastaurin-Treated Mantle Cell Lymphoma.

Marc Weinkauf, Grit Hutter, Yvonne Zimmermann, Elena Hartmann, MD, Andreas Rosenwald, Wolfgang Hiddemann, Martin H. Dreyling

Blood (2009) 114 (22): 1915.

https://doi.org/10.1182/blood.V114.22.1915.1915

Published: 2009

Journal Articles

High-level expression of the T-cell chemokines CCL3 and CCL4 by chronic lymphocytic leukemia B cells in nurselike cell cocultures and after BCR stimulation

Jan A. Burger, Maite P. Quiroga, Elena Hartmann, Andrea Bürkle, William G. Wierda, Michael J. Keating, Andreas Rosenwald

Blood (2009) 113 (13): 3050–3058.

https://doi.org/10.1182/blood-2008-07-170415

Published: 2009

Includes: Supplemental data

Journal Articles

A distinctive subtype of t(14;18)-negative nodal follicular non-Hodgkin lymphoma characterized by a predominantly diffuse growth pattern and deletions in the chromosomal region 1p36

Tiemo Katzenberger, Jörg Kalla, Ellen Leich, Heike Stöcklein, Elena Hartmann, Sandra Barnickel, Swen Wessendorf, M. Michaela Ott, Hans Konrad Müller-Hermelink, Andreas Rosenwald, German Ott

Blood (2009) 113 (5): 1053–1061.

https://doi.org/10.1182/blood-2008-07-168682

Published: 2009

Journal Articles

Molecular Signatures Implicate Innate Immune Cells, Fibrosis, and Angiogenesis in Survival Following R-CHOP Treatment of Diffuse Large B Cell Lymphoma

Blood (2008) 112 (11): 475.

https://doi.org/10.1182/blood.V112.11.475.475

Published: 2008

Journal Articles

High-Level Expression of the T Cell Chemokines CCL3 and CCL4 by Chronic Lymphocytic Leukemia B Cells in Nurselike Cell Co-Cultures and in Response to BCR Stimulation.

Jan A. Burger, MD, PhD, Matthias Niedermeier, PhD, Andrea Bürkle, MD, Elena Hartmann, MD, William G. Wierda, MD, PhD, Michael J. Keating, MD, Andreas Rosenwald, MD

Blood (2007) 110 (11): 342.

https://doi.org/10.1182/blood.V110.11.342.342

Published: 2007

Journal Articles

Gene Expression Signatures Predict Overall Survial in Diffuse Large B Cell Lymphoma Treated with Rituximab and Chop-Like Chemotherapy.

Georg Lenz, MD, George Wright, PhD, Sandeep Dave, MD, Alexander Kohlmann, PhD, Wenming Xiao, PhD, John Powell, MS, Hong Zhao, Weihong Xu, Randy D. Gascoyne, MD, Joseph M. Connors, MD, Lorraine May, MD, Dennis D. Weisenburger, MD, Tim Greiner, MD, Julie Vose, MD, James O. Armitage, MD, Javeed Iqbal, MD, Martin Bast, MD, Kai Fu, MD, Elias Campo, MD, Emili Montserrat, MD, Armando Lopez-Guillermo, MD, Pedro Jares, MD, Antonio Martinez, MD, Betty Gibbs, MD, Lisa M. Rimsza, MD, Richard I. Fisher, MD, Rita M. Braziel, MD, Ray Tubbs, MD, James Cook, MD, Brad Pohlman, MD, John Sweetenham, MD, Gunhild Troen, MD, Erlend B. Smeland, MD, Jan Delabie, MD, Stein Kvaloy, MD, Harald Holte, MD, Elaine S. Jaffe, MD, Wyndham H. Wilson, MD, Nicole Grant, MD, Elena Hartmann, MD, Andreas Rosenwald, MD, German Ott, MD, Hans-Konrad Muller-Hermelink, MD, T. Andrew Lister, MD, Mickey Williams, PhD, Lothar Wieczorek, PhD, Wing C. Chan, MD, Louis M. Staudt, MD, PhD

Blood (2007) 110 (11): 348.

https://doi.org/10.1182/blood.V110.11.348.348

Published: 2007

Journal Articles

Altered Cellular Protein Levels of Tumor Suppressor Genes and Heat Shock Elements (TRAP1) Indicate Sensitivity to the Proteasome Inhibitor Bortezomib (Velcade®) in Mantle Cell Lymphoma.

Marc Weinkauf, Malte Rieken, Alessandro Pastore, Elena Hartmann, Andreas Rosenwald, MD, Wolfgang Hiddemann, MD, Martin H. Dreyling, MD

Blood (2005) 106 (11): 2424.

https://doi.org/10.1182/blood.V106.11.2424.2424

Published: 2005

NARROW

Tumor and microenvironment response but no cytotoxic T-cell activation in classic Hodgkin lymphoma treated with anti-PD1

Risk of Central Nervous System (CNS) Involvement in Patients with Mantle Cell Lymphoma (MCL): Analysis of Clinico-Biological Factors in a Series of 283 Cases

Longitudinal Gene Expression Profiling Reveals Down-Regulation Of BCR Signaling-Related Genes In Chronic Lymphocytic Leukemia (CLL) Patients Treated With Ibrutinib Plus Rituximab

CCL3 (MIP-1α) plasma levels and the risk for disease progression in chronic lymphocytic leukemia

Stroma-Induced TCL1 Expression In Chronic Lymphocytic Leukemia Cells Is Associated with Down Regulation of TCL1A-Targeting miRNAs

Proteasome Inhibition Leads to Dephosphorylation and Downregulation of Protein Expression of Members of the Akt/mTOR Pathway In MCL

Enzastaurin Treatment Affects Multiple Regulatory Pathways at Transcriptome and Cellular Proteome Level of Mantle Cell Lymphoma

CCL3 and CCL4 Plasma Levels Correlate with Established Prognostic Markers in Chronic Lymphocytic Leukemia: Towards a Simple, ELISA-Based Assay for Risk Assessment.

Marrow Stromal Cells Induce TCL1 Expression in Chronic Lymphocytic Leukemia B Cells.

Synergistic Antilymphoma Effect of Protein Kinase C Beta (PKCβ) and mTOR Inhibition in Mantle Cell Lymphoma.

RNA-Expression and Proteome Analysis Identify Complementary but Not Identical Molecular Targets in Enzastaurin-Treated Mantle Cell Lymphoma.

High-level expression of the T-cell chemokines CCL3 and CCL4 by chronic lymphocytic leukemia B cells in nurselike cell cocultures and after BCR stimulation

A distinctive subtype of t(14;18)-negative nodal follicular non-Hodgkin lymphoma characterized by a predominantly diffuse growth pattern and deletions in the chromosomal region 1p36

Molecular Signatures Implicate Innate Immune Cells, Fibrosis, and Angiogenesis in Survival Following R-CHOP Treatment of Diffuse Large B Cell Lymphoma

High-Level Expression of the T Cell Chemokines CCL3 and CCL4 by Chronic Lymphocytic Leukemia B Cells in Nurselike Cell Co-Cultures and in Response to BCR Stimulation.

Gene Expression Signatures Predict Overall Survial in Diffuse Large B Cell Lymphoma Treated with Rituximab and Chop-Like Chemotherapy.

Altered Cellular Protein Levels of Tumor Suppressor Genes and Heat Shock Elements (TRAP1) Indicate Sensitivity to the Proteasome Inhibitor Bortezomib (Velcade®) in Mantle Cell Lymphoma.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only